Advertisement
Screener

BOSTON SCIENTIFIC CORPORATION (BSX) Material Contracts, 2024

BOSTON SCIENTIFIC CORPORATION Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2024-11-22: Form 8-K; Exhibit 10.3; Description Boston Scientific Corporation 2025 Organic Net Sales Growth Performance Share Program.
  • 2024-11-22: Form 8-K; Exhibit 10.2; Description Boston Scientific Corporation 2025 Relative Total Shareholder Return Performance Share Program.
  • 2024-11-22: Form 8-K; Exhibit 10.1; Description Boston Scientific Corporation 2025 Annual Bonus Plan, effective as of January 1, 2025.
  • 2024-08-01: Form 10-Q; Exhibit 10.1; Description Third Amendment, dated as of May 10, 2024, to the Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent..
FiledFormExhibitDescription
2024-11-228-K10.3Boston Scientific Corporation 2025 Organic Net Sales Growth Performance Share Program
2024-11-228-K10.2Boston Scientific Corporation 2025 Relative Total Shareholder Return Performance Share Program
2024-11-228-K10.1Boston Scientific Corporation 2025 Annual Bonus Plan, effective as of January 1, 2025
2024-08-0110-Q10.1Third Amendment, dated as of May 10, 2024, to the Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent.
2024-05-108-K10.1Third Amendment, dated as of May 10, 2024, to the Credit Agreement, dated as of May 10, 2021, by and among Boston Scientific Corporation, the lenders party thereto and Wells Fargo Bank, National Association, as administrative agent.
2024-05-0110-Q10.4Form of 2024 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Organic Net Sales Growth). #
2024-05-0110-Q10.3Form of 2024 Performance Share Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan (Total Shareholder Return). #
2024-05-0110-Q10.2Form of 2024 Global Restricted Stock Unit Award Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2024-05-0110-Q10.1Form of 2024 Global Non-Qualified Stock Option Agreement under the Company’s Amended and Restated 2011 Long-Term Incentive Plan. #
2024-02-2010-K10.30Boston Scientific Corporation Executive Retirement Plan, as amended and restated effective June 1, 2022. #

Similar stocks

Stock NameCountryMarket CapPE Ratio
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
3M CO (MMM)United States$86.404B27.87
DEXCOM INC (DXCM)United States$33.004B25.42
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
STRYKER CORP (SYK)United States$103.511B32.39
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12